The Case for Verifiable Biological Substrates

Modern biology generates massive datasets—single-cell and spatial biology experiments can produce 2–7 terabytes of data per run. This data is the raw material for training AI, but current frontier models struggle to extract scientific insight from it. The core challenge is that biology is inherently messy and lacks consensus. To improve, we must treat experimental biology as an "executable substrate" similar to how code serves as a verifiable substrate for software engineering. By decomposing research papers into specific, verifiable tasks, we can create benchmarks that reward reasoning over memorized knowledge.

Designing Robust Biological Benchmarks

LatchBio’s approach to benchmarking, exemplified by their "Spatial Bench," focuses on three critical properties:

• Verifiability: Success conditions must be checkable via programmatic functions (e.g., Python scripts) rather than subjective evaluation.
• Durability: Tasks must be invariant across different valid analysis paths. If a benchmark is poorly constructed, a model might "succeed" by taking a shortcut that isn't scientifically sound.
• Interaction-Driven: The model must interact with raw data (matrices, high-content images) rather than answering in a single turn.

Human verification is essential here. When LatchBio tested early iterations, they found that ambiguous prompts (e.g., "find an appropriate radius" for cell analysis) led to uninformative results. By having scientists grade each other's work, they identified that many canonical bioinformatics thresholds were arbitrary and that forcing a machine to perform these tasks often reveals a need for more rigorous, standardized scientific reasoning.

The Flywheel of Benchmark-Driven Development

Biological AI progress relies on a flywheel: build better benchmarks, improve model capabilities, index more of the drug discovery landscape, and repeat. This extends from routine tasks to "long-horizon" challenges, such as reconstructing metastatic niches in tumors. These complex tasks simulate real-world industry decisions, such as go/no-go drug program evaluations.

Furthermore, this framework addresses the "refusal problem" in biosecurity. Current models often refuse benign scientific questions due to over-sensitive safety filters. By building routine task benchmarks alongside red-team tasks, developers can measure the gap between helpfulness and safety, ensuring that models can assist in legitimate research without being hindered by excessive, non-contextual refusals.